compare_entities
Exposed by 1313 servers, with 2 different definitions behind the one name.
The same name does not mean the same tool here.
1313 servers expose compare_entities and we have recorded 2 distinct definitions of it. Compare the parameters below before assuming one is a drop-in for another.
NHL MCP — live NHL data via the official NHL API
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NHTSA MCP — wraps the NHTSA vPIC (Vehicle Product Information Catalog) API (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
UK NIHR (National Institute for Health and Care Research) open-data MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NIH RePORTER MCP — every NIH-funded research project (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NIST Randomness Beacon v2 — signed public random pulses every 60s.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NIST Standards MCP pack
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
New Jersey MVC inspection facilities and 2.3M inspection results by make and model
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NOAA Weather MCP — National Weather Service forecasts and alerts
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NOAA Storm Prediction Center — outlooks, storm reports, watches
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NOAA Space Weather Prediction Center (solar wind, Kp, aurora, alerts)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NOAA Tides & Currents — observations, predictions, datums, station metadata
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Nobel MCP — wraps the Nobel Prize API v2 (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Nominatim MCP — wraps OpenStreetMap Nominatim geocoding API (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Norges Bank (Norway's central bank) MCP — exchange rates, interest rates,
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NosDéputés.fr MCP — civic-tech mirror of the French Assemblée nationale
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Notion MCP Pack
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
CMS NPI Registry MCP
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
npm MCP — wraps the npm Registry API (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NPS MCP — US National Park Service (free key, generous limits)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NREL MCP — wraps the US National Renewable Energy Laboratory developer API
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
What this page is
Every field above is reproduced as the server published it at the time shown. The description and the annotations are claims by the server's author. Toolpin does not call tools, so we cannot tell you whether a tool does what it says.
What we can tell you is whether the claim changed. The hash covers the fields the MCP specification defines, so a vendor build stamp does not move it but a rewritten description does. See how we monitor, or this server's change history.